retatrutide fat loss results The next big shift in obesity care may not be surgery — it may be a weekly shot. Retatrutide, an investigational triple-action medicine, showed 28.3% average body-weight over 80 weeks in Retatrutide vs. Other Weight Loss

Its 95% correlation to polysomnography (PSG) ensures accurate measurement while also tracking advanced metrics like Hypoxic Burden

Studies on GLP-1 drugs consistently show that most of the lost weight returns within one to two years of stopping the drug if lifestyle changes are not maintained

Cosmeceutical peptides

Long-acting GLP-1 agonists like Retatrutide amplify and extend this signaling, producing sustained appetite suppression that enables significant weight loss

Retatrutide reaches pharmacokinetic steady state in approximately 4-5 weeks of consistent dosing at any given level

Secondly, efficacy is the core criterion for evaluating drugs, and currently, multi-target GLP-1 drugs have shown better efficacy